The Palliative Care Drug Access Program respects the dignity of people in the final stages of life by supporting their decision to choose where they would prefer to spend their final days.
This program is designed for people at the end stages of their illness, when the focus of care is on comfort. By covering the cost of eligible drugs for use in the home or in another residence, a major financial burden is removed for the patient and their family.
The Palliative Care Drug Access Program provides deductible-free coverage through Manitoba Health, Healthy Living and Seniors. Once the application has been processed by Manitoba Health, Healthy Living and Seniors, the costs of all eligible drugs prescribed by a physician will be covered. When filling their prescriptions at the pharmacy of their choice, individuals enrolled in the program will no longer be charged for their prescribed eligible medication.
The program is open to residents of Manitoba, with a current Manitoba Health registration number. The patient and physician must agree on palliative care, dealing with an advanced phase of a terminal illness.
When a physician makes a palliative diagnosis, an application form must be completed and signed by both the patient (and guardian) and a physician. The physician will then send the completed application form to the palliative care coordinator in the local regional health authority. If the patient is eligible for coverage, the form will be forwarded to Manitoba Health, Healthy Living and Seniors for registration.
Application forms are available to physicians through the palliative care coordinator at the regional health authority.
The patient or guardian will receive notification regarding acceptance into the program from their physician or palliative care coordinator.
Patients accepted into the program will be registered with the Palliative Care Drug Access Program and can obtain their eligible prescription drugs at no charge at the pharmacy of their choice.
Coverage will continue as long as the patient remains registered with the Palliative Care Drug Access Program